Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7503929 | 1.00 | ALDH1A1 (0.44) | ALDH1A1PKMHPGDGPR84MAPT | |
| SCHEMBL4521504 | 1.00 | ALDH1A1 (0.44) | ALDH1A1PKMHPGDGPR84MAPT | |
| SCHEMBL10088355 | 1.00 | ALDH1A1 (0.44) | ALDH1A1PKMHPGDGPR84MAPT | |
| SCHEMBL1148287 | 1.00 | ALDH1A1 (0.44) | ALDH1A1PKMHPGDGPR84MAPT | |
| SCHEMBL11933712 | 1.00 | ALDH1A1 (0.44) | ALDH1A1PKMHPGDGPR84MAPT | |
| SCHEMBL20915220 | 1.00 | ALDH1A1 (0.44) | ALDH1A1PKMHPGDGPR84MAPT | |
| SCHEMBL2703075 | 1.00 | ALDH1A1 (0.44) | ALDH1A1PKMHPGDGPR84MAPT | |
| SCHEMBL13519918 | 1.00 | ALDH1A1 (0.44) | ALDH1A1PKMHPGDGPR84MAPT | |
| SCHEMBL16837384 | 1.00 | ALDH1A1 (0.44) | ALDH1A1PKMHPGDGPR84MAPT | |
| SCHEMBL11933713 | 1.00 | ALDH1A1 (0.44) | ALDH1A1PKMHPGDGPR84MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3686207-B1 | TETRAZOLE SILANE COMPOUND, METHOD FOR SYNTHESIZING SAID COMPOUND AND USE THEREOF | SHIKOKU CHEM (JP) | 2024-10-23 | — | — | EP | disclosed |
| CN-114976010-B | Negative electrode additive and preparation method and application thereof | 深圳市研一新材料有限责任公司 | 2023-06-30 | — | — | CN | disclosed |
| CN-111108111-B | Tetrazole silane compound, method for synthesizing the compound, and use thereof | 四国化成工业株式会社 | 2023-05-02 | — | — | CN | disclosed |
| US-11472823-B2 | Tetrazole silane compound, method for synthesizing said compound and use thereof | SHIKOKU CHEMICALS CORPORATION (JP) | 2022-10-18 | — | — | US | disclosed |
| US-20210179642-A1 | TETRAZOLE SILANE COMPOUND, METHOD FOR SYNTHESIZING SAID COMPOUND AND USE THEREOF | SHIKOKU CHEMICALS CORPORATION (JP) | 2021-06-17 | — | — | US | disclosed |
| CN-108079981-B | Tetrazole/hydrophobic group bonded stationary phase and preparation method thereof | 中国科学院大连化学物理研究所 | 2021-06-08 | — | — | CN | disclosed |
| US-11014946-B2 | Tetrazole silane compound, method for synthesizing said compound and use thereof | SHIKOKU CHEMICALS CORPORATION (JP) | 2021-05-25 | — | — | US | disclosed |
| US-10975108-B2 | — | — | 2021-04-13 | — | — | US | disclosed |
| EP-3686207-A1 | TETRAZOLE SILANE COMPOUND, METHOD FOR SYNTHESIZING SAID COMPOUND AND USE THEREOF | Shikoku Chemicals Corporation (JP) | 2020-07-29 | — | — | EP | disclosed |
| US-20200223875-A1 | TETRAZOLE SILANE COMPOUND, METHOD FOR SYNTHESIZING SAID COMPOUND AND USE THEREOF | SHIKOKU CHEMICALS CORPORATION (JP) | 2020-07-16 | — | — | US | disclosed |
| US-20110009620-A1 | 4-Amino-5-cyanopyrimidine derivatives | OTSUKA PHARMACEUTICAL CO., LTD. | 2011-01-13 | — | — | US | disclosed |
| US-7834002-B2 | 4-amino-5-cyanopyrimidine derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2010-11-16 | — | — | US | disclosed |
| US-20100173835-A1 | Peptides for Treatment of Obesity | NOVO NORDISK A/S (DK) | 2010-07-08 | — | — | US | disclosed |
| US-20100173835-A1 | Peptides for Treatment of Obesity | NOVO NORDISK A/S (DK) | 2010-07-08 | — | — | US | disclosed |
| US-20080182854-A1 | 4-Amino-5-Cyanopyrimidine Derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2008-07-31 | — | — | US | disclosed |
| EP-1740574-B1 | 4-AMINO-5-CYANOPYRIMIDINE DERIVATIVES | OTSUKA PHARMA CO LTD (JP) | 2007-06-27 | — | — | EP | disclosed |
| EP-1740574-A2 | 4-AMINO-5-CYANOPYRIMIDINE DERIVATIVES | Otsuka Pharmaceutical Company, Limited (JP) | 2007-01-10 | — | — | EP | disclosed |
| WO-2005105778-A2 | 4-AMINO-5-CYANOPYRIMIDINE DERIVATIVES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-11-10 | — | — | WO | disclosed |
| US-4647572-A | Iodoallyl and iodopropargyl substituted tetrazoles and anti-microbial compositions thereof | MEIJI SEIKA KAISHA, LTD. (JP) | 1987-03-03 | — | — | US | disclosed |
| EP-0107859-A1 | Tetrazole compounds, process for preparing the same and antibacterial and antifungal compositions containing the same as active ingredient | MEIJI SEIKA KAISHA LTD. (JP) | 1984-05-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009620-A1 | 4-Amino-5-cyanopyrimidine derivatives | ADORA2A, ADORA1, ADORA3 | ALDH1A1 381/4885PKM 1983/4885HPGD 781/4885 |
| US-20080182854-A1 | 4-Amino-5-Cyanopyrimidine Derivatives | ADORA2A, ADORA1, ADORA3 | ALDH1A1 381/4885PKM 1983/4885HPGD 781/4885 |
| US-11472823-B2 | Tetrazole silane compound, method for synthesizing said compound and use thereof | TST, ITGA5, TPX2 | ALDH1A1 1587/4885PKM 1852/4885HPGD 4209/4885 |
| US-10975108-B2 | — | ITGA5, ITGB5, ITGA1 | ALDH1A1 845/4885PKM 3013/4885HPGD 3509/4885 |
| US-20200223875-A1 | TETRAZOLE SILANE COMPOUND, METHOD FOR SYNTHESIZING SAID COMPOUND AND USE THEREOF | TST, ITGA5, TPX2 | ALDH1A1 1587/4885PKM 1852/4885HPGD 4209/4885 |
| US-11014946-B2 | Tetrazole silane compound, method for synthesizing said compound and use thereof | TST, ITGA5, TPX2 | ALDH1A1 1587/4885PKM 1852/4885HPGD 4209/4885 |
| US-20100173835-A1 | Peptides for Treatment of Obesity | MC4R, GIPR, MC3R | ALDH1A1 4086/4885PKM 2285/4885HPGD 3314/4885 |
| US-20210179642-A1 | TETRAZOLE SILANE COMPOUND, METHOD FOR SYNTHESIZING SAID COMPOUND AND USE THEREOF | TST, ITGA5, TPX2 | ALDH1A1 1587/4885PKM 1852/4885HPGD 4209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.